Amid the spread of COVID-19, testing for SARS-COV-2, the virus that causes it, is at the forefront of the battle. Patients rely on test results to confirm if they’ve acquired the coronavirus, and public health entities around globe rely on the data to learn how and where the virus is spreading.
Managing the Risks of Antimicrobial Resistance Concurrently with COVID-19
Patients at the greatest risk for secondary infections, particularly infections that are resistant to first-line antibiotics, include people who are already vulnerable due to other conditions and diseases—like COVID-19. Because of that, antimicrobial resistance poses a significant additional threat, especially as healthcare systems become overburdened.
The Worldwide Burden of Multi-drug Resistant Tuberculosis
The World Health Organization (WHO) estimates that Tuberculosis (TB) caused 1.5 million deaths in 2018. It’s one of the top ten causes of death worldwide and the leading cause of death from a single infectious agent.
Responding to COVID-19 in a Climate of Uncertainty
As COVID-19 continues to spread, misinformation has often been more contagious than the virus itself, and a lack of concrete information in some areas has compounded the problem.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...